Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.392
-0.003 (-0.63%)
At close: Mar 9, 2026, 4:00 PM EDT
0.385
-0.006 (-1.61%)
After-hours: Mar 9, 2026, 7:41 PM EDT

Mereo BioPharma Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
6254232388174242
Upgrade
Market Cap Growth
-85.98%67.64%269.38%-49.64%-28.05%276.02%
Upgrade
Enterprise Value
154682821750221
Upgrade
Last Close Price
0.393.502.310.751.603.58
Upgrade
PE Ratio
----10.09-
Upgrade
PS Ratio
126.48-32.34-3.52-
Upgrade
PB Ratio
1.358.896.401.701.46-11.82
Upgrade
P/TBV Ratio
1.388.996.541.702.02-
Upgrade
EV/Sales Ratio
29.88-28.17-1.02-
Upgrade
Debt / Equity Ratio
0.010.110.120.300.19-1.20
Upgrade
Net Debt / Equity Ratio
-1.04-1.04-1.02-1.03-0.880.37
Upgrade
Net Debt / EBITDA Ratio
1.071.401.941.013.720.15
Upgrade
Net Debt / FCF Ratio
1.481.932.441.0813.430.20
Upgrade
Asset Turnover
0.01-0.14-0.39-
Upgrade
Quick Ratio
8.355.246.382.897.663.23
Upgrade
Current Ratio
8.715.406.723.097.923.47
Upgrade
Return on Equity (ROE)
-69.79%-77.58%-57.81%-53.63%34.85%-1294.27%
Upgrade
Return on Assets (ROA)
-39.81%-39.99%-23.57%-28.67%-13.82%-31.43%
Upgrade
Return on Invested Capital (ROIC)
----825.95%--220.12%
Upgrade
Return on Capital Employed (ROCE)
-95.30%-73.10%-47.60%-99.40%-18.40%-69.10%
Upgrade
Earnings Yield
-65.74%-7.98%-9.11%-48.22%9.91%-92.45%
Upgrade
FCF Yield
-51.75%-6.06%-6.54%-55.78%-4.50%-16.02%
Upgrade
Buyback Yield / Dilution
-9.71%-12.16%-9.33%-8.63%-63.82%-279.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.